Here are relevant reports on : North-American Drug Delivery Technologies Market
-
Ocular Implants Market by Product (Intraocular Lens, Glaucoma Implants, Orbital Implants), Application (Glaucoma surgery, Oculoplasty, Drug Delivery, Ocular Prosthesis), End User (Hospital, Specialty Eye Institutes) and Geography - Global Forecast to 2027
The global ocular implants market size is projected to reach USD 18,824.1 million by 2027 from USD 14,033.3 million in 2022, at a CAGR of 6.1% during the forecast period. Market is driven by factors such as increasing incidence of eye disorders such as age-related macular degeneration, glaucoma, corneal disease, and scleritis, increased time spent on virtual devices, and rising geriatric and diabetic population.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Petroleum Fuel Optimization Technologies Market - By Technologies and Geography: Trends & Forecasts to 2019
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Medical Plastics Market by Type (Engineering Plastics, HPP, Standard Plastics, Silicone, and Others), Application (Medical Disposables, Prosthetics, Medical Instruments & Tools, Drug Delivery, and Others), Region - Global Forecast to 2024
The Medical Plastics Market is expected to grow from USD 22.8 billion in 2019 to USD 31.7 billion by 2024, at a compound annual growth rate (CAGR) of 6.8%. during the forecast period.SABIC (Saudi Arabia), BASF (Germany), Celanese (US), Evonik (Germany), Solvay (Belgium), and Covestro (Germany) are some of the leading market players. New product launch, agreement & collaboration, investment & expansion, and merger & acquisition were the major growth strategies adopted by the market players between 2017 and 2019 to enhance their regional presence and meet the growing demand for medical plastics in the emerging economies.
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
Asia Pacific Pharmaceutical Drug Delivery Market by Route of Administration (Oral, Injectors (Auto Injectors), Implantable, Transmucosal, Nasal, Syringes), Application (Cancer, Diabetes), Care Setting (Hospital, Home Care) - Global Forecast to 2031
The Asia Pacific (APAC) pharmaceutical drug delivery market is projected to reach USD 687.9 million by 2031 from USD 479.7 million in 2026 at a CAGR of 7.5% during the forecast period. Some of the major players in the APAC pharmaceutical drug delivery market include Johnson & Johnson Services, Inc. (US), Pfizer Inc. (US), Terumo Corporation (Japan), Becton, Dickinson and Company (US), Merck & Co., Inc. (US), B. Braun (Germany), Gerresheimer AG (Germany), Cipla (India), Eli Lilly and Company (US), Novartis (Switzerland), Biogen (US), Baxter International (US), West Pharmaceutical Services (US), Sun Pharmaceutical Industries (India), GlaxoSmithKline (UK).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
COVID-19 Impact On Medical Plastics Market by Type (Engineering Plastics and Standard Plastics), Application (Medical Disposables, Prosthetics, Medical Instruments & Tools and Drug Delivery) and Region - Global Forecast to 2021
The COVID-19 Impact On medical plastics market is expected to grow from USD 25.1 billion in 2020 to USD 29.4 billion by 2021 at a compound annual growth rate (CAGR) of 17.2% during the forecast period.SABIC (Saudi Arabia), BASF (Germany), Celanese (US), Evonik (Germany), Solvay (Belgium), and Covestro (Germany) are some of the leading market players in the global medical plastics market. CSR activities, increase in production, and partnerships were the major growth strategies adopted by the market players during this period to enhance their regional presence and meet the growing demand for medical plastics in the affected regions.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
US Pharmaceutical Drug Delivery Market by Route of Administration [Oral (Tablet, Capsule), Injectable, Topical (Cream, Transdermal, Suppositories), Ocular, Nasal, Transmucosal, Implantable], Application (Cancer, Diabetes), Care Setting - Forecast to 2031
The US pharmaceutical drug delivery market is projected to reach USD 1.24 billion by 2031 from USD 0.94 billion in 2026, at a CAGR of 5.8% during the forecast period. Some of the prominent players in the US pharmaceutical drug delivery market include Johnson & Johnson Services, Inc. (US), Pfizer Inc. (US), F. Hoffmann-La Roche (Switzerland), Becton, Dickinson and Company (US), Merck & Co., Inc. (US), Amgen, Inc. (US), AbbVie Inc. (US), Gilead Sciences, Inc. (US), Eli Lilly and Company (US), Bristol-Myers Squibb (US), Biogen (US), Baxter International (US), West Pharmaceutical Services (US), Catalent Pharma Solutions (US), and Novartis (Switzerland).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Middle East & Africa Injectable Drug Delivery Market by Product (Device, Needle-free injectors, Formulation, Solutions), Formulation Packaging (Vials, Cartridges), Therapeutic Application (Diabetes, Psoriasis), Site of Administration – Forecast to 2031
The Middle East & Africa injectable drug delivery market is projected to reach USD 22.54 billion by 2031 from USD 16.46 billion in 2026, at a CAGR of 6.5% during the forecast period.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.
- Published: July 2015
- Price: $ 4950
- TOC Available:
-
Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029
The global microfluidics market, valued at US$21.36 billion in 2023, stood at US$22.43 billion in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$32.67 billion by the end of the period. The rising requirement of point-of-care diagnostics is an important factor, that helps to detect cancer, infectious diseases, and chronic illnesses, for which microfluidic devices are preferred due to their accuracy.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029
The global pharmaceutical drug delivery market, valued at US$1,831.1 million in 2023, stood at US$1,949.4 million in 2024 and is projected to advance at a resilient CAGR of 5.5% from 2024 to 2029, culminating in a forecasted valuation of US$2,546.0 million by the end of the period. The increasing patient population with chronic diseases, coupled with the growing geriatric population, rising technological advancements in pharmaceutical drug delivery products offering enhanced patient convenience and compliance, the growing adoption of home-based and self-administration, rising government initiatives promoting accessibility to pharmaceutical drug delivery, and the increasing demand for biosimilars and biologics are likely to support market growth.
- Published: September 2024
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
